25T7-NBOMe (also known as 2C-T-7-NBOMe or NBOMe-2C-T-7), is a substituted phenethylamine derivative from the 25-NB family. It acts as an agonist at the 5-HT2A and 5-HT2C serotonin receptors, has psychedelic effects and has been sold as a designer drug.[1][2][3][4] It is illegal in Brazil.[5]

See also

References

  1. ^ Rickli A, Hoener MC, Liechti ME (September 2019). "Pharmacological profiles of compounds in preworkout supplements ("boosters")". European Journal of Pharmacology. 859: 172515. doi:10.1016/j.ejphar.2019.172515. PMID 31265842.
  2. ^ Botch-Jones S, Foss J, Barajas D, Kero F, Young C, Weisenseel J (October 2016). "The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography". Forensic Science International. 267: 89–95. doi:10.1016/j.forsciint.2016.08.008. PMID 27572638.
  3. ^ Grumann C, Auwärter V (February 2018). "Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry". Drug Testing and Analysis. 10 (7): 1184–1191. doi:10.1002/dta.2371. PMID 29455470.
  4. ^ Fan SY, Zang CZ, Shih PH, Ko YC, Hsu YH, Lin MC, et al. (August 2021). "Simultaneous LC-MS/MS screening for multiple phenethylamine-type conventional drugs and new psychoactive substances in urine". Forensic Science International. 325: 110884. doi:10.1016/j.forsciint.2021.110884. PMID 34245937. S2CID 235791505.
  5. ^ "Resolução da Diretoria Colegiada - RDC N° 159" [Resolution of the Collegiate Board - RDC No. 159] (PDF). Ministério da Saúde Agência Nacional de Vigilância Sanitária [Ministry of Health National Health Surveillance Agency] (in Portuguese). 2 June 2017.